284 related articles for article (PubMed ID: 35479740)
1. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects.
Okabe K; Yaku K; Uchida Y; Fukamizu Y; Sato T; Sakurai T; Tobe K; Nakagawa T
Front Nutr; 2022; 9():868640. PubMed ID: 35479740
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Yi L; Maier AB; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V
Geroscience; 2023 Feb; 45(1):29-43. PubMed ID: 36482258
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
Katayoshi T; Uehata S; Nakashima N; Nakajo T; Kitajima N; Kageyama M; Tsuji-Naito K
Sci Rep; 2023 Feb; 13(1):2786. PubMed ID: 36797393
[TBL] [Abstract][Full Text] [Related]
4. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women.
Fukamizu Y; Uchida Y; Shigekawa A; Sato T; Kosaka H; Sakurai T
Sci Rep; 2022 Aug; 12(1):14442. PubMed ID: 36002548
[TBL] [Abstract][Full Text] [Related]
5. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.
Igarashi M; Nakagawa-Nagahama Y; Miura M; Kashiwabara K; Yaku K; Sawada M; Sekine R; Fukamizu Y; Sato T; Sakurai T; Sato J; Ino K; Kubota N; Nakagawa T; Kadowaki T; Yamauchi T
NPJ Aging; 2022 May; 8(1):5. PubMed ID: 35927255
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
Yamaguchi S; Irie J; Mitsuishi M; Uchino Y; Nakaya H; Takemura R; Inagaki E; Kosugi S; Okano H; Yasui M; Tsubota K; Hayashi K; Yoshino J; Itoh H
Endocr J; 2024 Feb; 71(2):153-169. PubMed ID: 38191197
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
Yamane T; Imai M; Bamba T; Uchiyama S
Clin Nutr ESPEN; 2023 Aug; 56():83-86. PubMed ID: 37344088
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
Irie J; Inagaki E; Fujita M; Nakaya H; Mitsuishi M; Yamaguchi S; Yamashita K; Shigaki S; Ono T; Yukioka H; Okano H; Nabeshima YI; Imai SI; Yasui M; Tsubota K; Itoh H
Endocr J; 2020 Feb; 67(2):153-160. PubMed ID: 31685720
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide Mononucleotide Is Safely Metabolized and Significantly Reduces Blood Triglyceride Levels in Healthy Individuals.
Kimura S; Ichikawa M; Sugawara S; Katagiri T; Hirasawa Y; Ishikawa T; Matsunaga W; Gotoh A
Cureus; 2022 Sep; 14(9):e28812. PubMed ID: 36225528
[TBL] [Abstract][Full Text] [Related]
10. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.
Morifuji M; Higashi S; Ebihara S; Nagata M
Geroscience; 2024 May; ():. PubMed ID: 38789831
[TBL] [Abstract][Full Text] [Related]
11. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Ugamraj HS; Dang K; Ouisse LH; Buelow B; Chini EN; Castello G; Allison J; Clarke SC; Davison LM; Buelow R; Deng R; Iyer S; Schellenberger U; Manika SN; Bijpuria S; Musnier A; Poupon A; Cuturi MC; van Schooten W; Dalvi P
MAbs; 2022; 14(1):2095949. PubMed ID: 35867844
[TBL] [Abstract][Full Text] [Related]
12. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
Song Q; Zhou X; Xu K; Liu S; Zhu X; Yang J
Adv Nutr; 2023 Nov; 14(6):1416-1435. PubMed ID: 37619764
[TBL] [Abstract][Full Text] [Related]
13. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.
Pencina KM; Lavu S; Dos Santos M; Beleva YM; Cheng M; Livingston D; Bhasin S
J Gerontol A Biol Sci Med Sci; 2023 Jan; 78(1):90-96. PubMed ID: 35182418
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
Nadeeshani H; Li J; Ying T; Zhang B; Lu J
J Adv Res; 2022 Mar; 37():267-278. PubMed ID: 35499054
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism.
Hong W; Mo F; Zhang Z; Huang M; Wei X
Front Cell Dev Biol; 2020; 8():246. PubMed ID: 32411700
[TBL] [Abstract][Full Text] [Related]
16. Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration.
Kuerec AH; Wang W; Yi L; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V; Maier AB
Mech Ageing Dev; 2024 Apr; 218():111917. PubMed ID: 38430946
[TBL] [Abstract][Full Text] [Related]
17. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.
Ramanathan C; Lackie T; Williams DH; Simone PS; Zhang Y; Bloomer RJ
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057482
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
Mills KF; Yoshida S; Stein LR; Grozio A; Kubota S; Sasaki Y; Redpath P; Migaud ME; Apte RS; Uchida K; Yoshino J; Imai SI
Cell Metab; 2016 Dec; 24(6):795-806. PubMed ID: 28068222
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
Park JH; Long A; Owens K; Kristian T
Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894
[TBL] [Abstract][Full Text] [Related]
20. Exercise-induced benefits on glucose handling in a model of diet-induced obesity are reduced by concurrent nicotinamide mononucleotide.
Yu J; Laybutt DR; Kim LJ; Quek LE; Wu LE; Morris MJ; Youngson NA
Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E176-E189. PubMed ID: 34121447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
